Hans B. Liu

Hans B. Liu

Auto-generated profile, based on publicly available information

Hans B. Liu

Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
FWFengrong Wang
Fengrong Wang
SCSong Chen
Song Chen
HLHans B. Liu
Hans B. Liu
CPCarole A. Parent
Carole A. Parent
PCPierre A. Coulombe
Pierre A. Coulombe
The a and b isoforms of keratin 6 (K6), a type II intermediate filament (IF) protein, are robustly induced upon injury to interfollicular epidermis. We previously showed that complete loss of K6a/K6b stimulates keratinocyte migration, correlating with enhanced Src activity. In this study, we demonstrate that this property is cell autonomous, depends on the ECM, and results from elevated speed, enhanced directionality, and an increased rate of focal adhesion disassembly. We show that myosin IIA interacts with K6a/K6b, that its levels are markedly reduced in Krt6a/Krt6b-null keratinocytes, and that inhibiting myosin ATPase activity normalizes the enhanced migration potential of Krt6a/Krt6b-null cells. Desmoplakin, which mediates attachment of IFs to desmosomes, is also expressed at reduced levels and is mislocalized to the nucleus in Krt6a/Krt6b-null cells, correlating with defects in cell adhesion. These findings reveal that K6a/K6b modulate keratinocyte migration by regulating cell–matrix and cell–cell adhesion and highlight a role for keratins in collective cell migration.

14 February 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
RSRussell P. Swift
Russell P. Swift
KRKrithika Rajaram
Krithika Rajaram
HLHans B. Liu
Hans B. Liu
ADAmanda Dziedzic
Amanda Dziedzic
AJAnne E. Jedlicka
Anne E. Jedlicka
SPSean T. Prigge
Sean T. Prigge
Malaria parasites rely on a plastid organelle for survival during the blood stages of infection. However, the entire organelle is dispensable as long as the isoprenoid precursor, isopentenyl pyrophosphate (IPP), is supplemented in the culture medium. We engineered parasites to produce isoprenoid precursors from a mevalonate-dependent pathway, creating a parasite line that replicates normally after the loss of the apicoplast organelle. We show that carbon-labeled mevalonate is specifically incorporated into isoprenoid products, opening new avenues for researching this essential class of metabolites in malaria parasites. We also show that essential apicoplast proteins, such as the enzyme target of the drug fosmidomycin, can be deleted in this mevalonate bypass parasite line, providing a new method to determine the roles of other important apicoplast-resident proteins. Several antibacterial drugs kill malaria parasites by targeting basic processes, such as transcription, in the organelle. We used metabolomic and transcriptomic methods to characterize parasite metabolism after azithromycin treatment triggered loss of the apicoplast and found that parasite metabolism and the production of apicoplast proteins is largely unaltered. These results provide insight into the effects of apicoplast-disrupting drugs, several of which have been used to treat malaria infections in humans. Overall, the mevalonate bypass system provides a way to probe essential aspects of apicoplast biology and study the effects of drugs that target apicoplast processes. Malaria parasites rely on an organelle called the apicoplast for growth and survival. Antimalarial drugs such as azithromycin inhibit basic processes in the apicoplast and result in the disruption of the organelle. Surprisingly, addition of a single metabolite, isopentenyl pyrophosphate (IPP), allows the parasites to survive in culture after disruption of the apicoplast. Unfortunately, using IPP to study this phenomenon has several limitations: IPP is prohibitively expensive, has to be used at high concentrations, and has a half-life less than 5 hours. To address these problems, we engineered parasites to express four enzymes from an alternative pathway capable of producing IPP in the parasites. We validated this new system and used it to metabolically label essential metabolites, to delete an essential apicoplast protein, and to characterize the state of apicoplast disrupted parasites. A key finding from these studies comes from transcriptomic and metabolomic analysis of parasites treated with the drug azithromycin. We found that apicoplast disruption results in few changes in parasite metabolism. In particular, the expression of hundreds of nuclear-encoded apicoplast proteins are not affected by disruption of the apicoplast organelle, making it likely that apicoplast metabolic pathways and processes are still functional in apicoplast disrupted parasites.

24 August 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
ALAna Lustig
Ana Lustig
HLHans B. Liu
Hans B. Liu
EME. Jeffrey Metter
E. Jeffrey Metter
YAYang An
Yang An
MSMelissa A. Swaby
Melissa A. Swaby
NWNan-Ping Weng
Nan-Ping Weng
A number of biological parameters have been cited as hallmarks of immune aging. However, it is not clear whether these multiple biological changes are the result of common underlying aging processes and follow correlated trajectories, or whether the patterns of change for multiple parameters vary across individuals and reflect heterogeneity in the aging process. Here, we have studied parameters of immune system aging through longitudinal analysis of telomere length, inflammatory cytokines, and antibody titer to CMV in 465 subjects ranging in age from 21 to 88 at the first visit, with an average of 13 years (7-19 years) follow-up. We observed a highly variable rate of change in telomere length of PBMCs with a relatively slow average rate of telomere shortening (-16 bp/year). Similarly, there were significant increases with age in vivo in three inflammatory-related cytokines (IFN-, IL-6 and IL-10) and in anti-CMV IgG titer, which varied widely across individuals as well. We further observed positive correlative changes among different inflammatory cytokines. However, we did not find significant correlations among the rate of changes in telomere length, inflammatory cytokines, and anti-CMV IgG titers. Our findings thus reveal that age-related trajectories of telomere attrition, elevated circulating inflammatory cytokines, and anti-CMV IgG are independent, and that aging individuals do not show a uniform pattern of change in these variables. Immune aging processes are complex and vary across individuals, and the use of multiple biomarkers is essential to evaluation of biological aging of the immune system.

20 August 2020 in eLife
Verified
Journal Article
Open access
RSRussell P Swift
Russell P Swift
KRKrithika Rajaram
Krithika Rajaram
CKCyrianne Keutcha
Cyrianne Keutcha
HLHans B Liu
Hans B Liu
BKBobby Kwan
Bobby Kwan
SPSean T Prigge
Sean T Prigge
The apicoplast of Plasmodium falciparum parasites is believed to rely on the import of three-carbon phosphate compounds for use in organelle anabolic pathways, in addition to the generation of energy and reducing power within the organelle. We generated a series of genetic deletions in an apicoplast metabolic bypass line to determine which genes involved in apicoplast carbon metabolism are required for blood-stage parasite survival and organelle maintenance. We found that pyruvate kinase II (PyrKII) is essential for organelle maintenance, but that production of pyruvate by PyrKII is not responsible for this phenomenon. Enzymatic characterization of PyrKII revealed activity against all NDPs and dNDPs tested, suggesting that it may be capable of generating a broad range of nucleotide triphosphates. Conditional mislocalization of PyrKII resulted in decreased transcript levels within the apicoplast that preceded organelle disruption, suggesting that PyrKII is required for organelle maintenance due to its role in nucleotide triphosphate generation.

1 December 2018 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
EPElizabeth J. Pantesco
Elizabeth J. Pantesco
DLDaniel K. Leibel
Daniel K. Leibel
JAJason J. Ashe
Jason J. Ashe
SWShari R. Waldstein
Shari R. Waldstein
LKLeslie I. Katzel
Leslie I. Katzel
DMDanielle L. Beatty Moody
Danielle L. Beatty Moody

1 February 2019 in Biological Psychology
Verified
Journal Article
Closed access
DMDanielle L. Beatty Moody
Danielle L. Beatty Moody
DLDaniel K. Leibel
Daniel K. Leibel
TDTaylor M. Darden
Taylor M. Darden
JAJason J. Ashe
Jason J. Ashe
SWShari R. Waldstein
Shari R. Waldstein
AZAlan B. Zonderman
Alan B. Zonderman